- Conditions
- Coronary Arteriosclerosis, Non ST Segment Elevation Acute Coronary Syndrome
- Interventions
- OrbusNeich Combo stent™, Everolimus Eluting Stent (EES)
- Device
- Lead sponsor
- OrbusNeich
- Industry
- Eligibility
- 20 Years and older
- Enrollment
- 572 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2021
- U.S. locations
- 17
- States / cities
- Washington D.C., District of Columbia • Lake Worth, Florida • Miami, Florida + 14 more
Source: ClinicalTrials.gov public record
Updated May 12, 2022 · Synced May 21, 2026, 7:49 PM EDT